Quantcast

Latest Antibody Stories

2014-02-05 20:26:52

SOUTH SAN FRANCISCO, Calif., Feb. 5, 2014 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that David Pritchard, President and Chief Executive Officer, will be presenting at the following upcoming investor conferences: -- 16(th) Annual BIO CEO & Investor ConferenceTuesday, February 11, 2014 in New York City8:30 AM Eastern Time (5:30 AM Pacific Time) -- Leerink Global Healthcare Conference 2014Thursday, February 13, 2014 in New...

2014-02-04 12:28:06

SAN DIEGO, Atlanta and AACHEN, Germany, February 4, 2014 /PRNewswire/ -- Research resources reported in the biomedical literature often lack sufficient detail to be uniquely identified, which can hinder scientific reproducibility. To address this problem, an international collaboration between researchers, program officers, vendors, curators, editors, computer scientists and publishers has started the Resource Identification Initiative...

2014-01-31 23:24:23

OriGene Technologies, Inc. (“OriGene”), one of the industry leaders in producing genome wide products for research and diagnostic applications, has been awarded a contract from the National Cancer Institute (NCI) to develop high affinity anti-peptide antibodies for SISCAPA assays. Rockville, MD (PRWEB) January 31, 2014 Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA), an approach developed by Dr. Leigh Anderson, is a novel technology that can achieve high...

2014-01-30 11:07:19

University of British Columbia researchers have discovered a potential new treatment for a rare blood cancer that may also point the way to treating other more common diseases. Paroxysmal nocturnal hemoglobinemia (PNH) is a rare form of cancer characterized by episodic rupture of red blood cells and the danger of blood clots forming in the vascular system. The condition results in red blood cells becoming vulnerable to attacks by the body's own complement immune system and can lead to...

2014-01-24 23:22:40

The USDA issues license for first commercial West Nile Virus antibody detection kit for horses. Seattle, WA (PRWEB) January 24, 2014 A USDA licensed West Nile Virus (WNV) diagnostic kit for horses is now commercially available to veterinary and reference laboratories in the United States. The West Nile Virus Antibody Test Kit, ELISA was developed at InBios using antigen reagents licensed from the Centers for Disease Control (CDC) and is manufactured at InBios’ licensed USDA facility in...

2014-01-24 23:01:47

Comprehensive research study “Global and China Monoclonal Antibody Industry Report, 2013-2017” elaborated by ResearchInChina has been recently published by Market Publishers Ltd. According to the report, China is forecast to account for a market share of 21.5% of the overall monoclonal antibody market by 2017. London, UK (PRWEB) January 24, 2014 At present, monoclonal antibody agents are successfully being used in the treatment of many serious diseases, such as cancers and tumours....

2014-01-23 04:21:26

LONDON and BOSTON, January 23, 2014 /PRNewswire/ -- Stabilised GPCR (StaR(R)) Proteins Delivered For All Nominated Targets Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, has successfully completed the research phase of its antibody drug discovery collaboration with MedImmune, the global biologics research and development arm of AstraZeneca. In achieving this milestone, Heptares has delivered StaR(R) proteins...

2014-01-22 08:28:34

Patent Provides Coverage for Lpath's Anti-S1P Antibody in the Treatment of a Wide Variety of Ocular Disorders, Including Wet AMD SAN DIEGO, Jan. 22, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, received official notification from the U.S. Patent and Trademark Office that the company has been issued another key patent supporting its iSONEP(TM) program. The newly issued U.S. patent, No. 8,614,103, is entitled,...

2014-01-16 23:27:40

Study indicates potential for TauC3 to be disease-modifying. Englewood Cliffs, New Jersey (PRWEB) January 16, 2014 Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic and diagnostic agents for the treatment of Alzheimer's and other neurological diseases, today announced it obtained proof of concept in a preclinical Alzheimer's model for its TauC3 monoclonal antibody indicating its...

2014-01-15 08:29:14

OXFORD, England and SAN JOSE, California, January 15, 2014 /PRNewswire/ -- Oxford BioTherapeutics, an international biotechnology company developing antibody-drug conjugates for cancer, today announced the appointment of Thomas C Reynolds MD, PhD to its Board of Directors. Dr Reynolds has over 20 years' development experience gained in the biotechnology industry, most recently as Chief Medical Officer at Seattle Genetics. "I am delighted to welcome Tom at this...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related